1. From the Department of Global Health and Social Medicine, Harvard Medical School (S.H.P.), and the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital (A.S.K.) — both in Boston.